BLK
BlackRock, Inc.
BLK's fundamentals are mixed, but it looks expensive: trading at 28x earnings, above its usual 22x.
CNCK
Coincheck Group N.V.
There isn't enough reported data to score CNCK yet.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
CNCK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
CNCK's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CNCK.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
CNCK PE Valuation
CNCK has no meaningful PE right now: it lost money over the past year.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
CNCK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| Stable | |
| Limited | |
| Low |
Analysts expect CNCK's losses to grow, with revenue declining. However, they disagree widely on these estimates.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK has the edge over CNCK on earnings quality, reporting a profit while its opponent remains loss making.
CNCK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.06 | +$0.71 |
| Q1 2026 | -$0.09 | +$0.33 |
| Q4 2025 | -$0.00 | -100% |
| Q3 2025 | -$0.76 | -142% |
| Q2 2025 | -$0.77 | -145% |
| Q1 2025 | -$0.42 | -134% |
| Q4 2024 | $0.77 | +1825% |
| Q1 2022 | $16.51 | -60% |
CNCK is still losing money, but far less than before: $0.06 per share over the past year, against $0.77 at its worst in mid-2025.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK's revenue has grown year over year for 13 quarters in a row: $7.8B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK has the edge over CNCK on profitability, with a higher operating margin.
CNCK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $716.6M | +36% |
| Q1 2026 | $750.3M | +4.5% |
| Q4 2025 | $899.2M | +17% |
| Q3 2025 | $834.3M | +89% |
| Q2 2025 | $526.4M | +12% |
| Q1 2025 | $718.2M | +13% |
| Q4 2024 | $771.6M | +108% |
| Q3 2024 | $440.9M | +88% |
CNCK has the edge over BLK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.2% | -0.2 points |
| Q1 2026 | -1.2% | -1.1 points |
| Q4 2025 | 0.6% | +13 points |
| Q3 2025 | 0.7% | +0.7 points |
| Q2 2025 | -1% | -1.9 points |
| Q1 2025 | 0% | -2.4 points |
| Q4 2024 | -12% | -14 points |
| Q3 2024 | 0% | +0.3 points |
CNCK's operating margin was −1.2% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2020.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK has the edge over CNCK on cash generation, producing positive trailing cash flow while its opponent burns cash.
CNCK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$9.1M | -277% |
| Q1 2026 | -$2.9M | +$9.1M |
| Q4 2025 | $12.2M | +$16.3M |
| Q3 2025 | -$8.5M | -$3.5M |
| Q2 2025 | $5.2M | +11% |
| Q1 2025 | -$12M | -204% |
| Q4 2024 | -$4.1M | -149% |
| Q3 2024 | -$4.9M | -995% |
CNCK's free cash flow was −$8M over the past year, against −$16M the year before. Free cash flow isn't a meaningful measure for financial services companies like CNCK.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has the edge over CNCK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
CNCK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +41% | +56M shares |
| 1 year | +47% | +61M shares |
| 3 years | +1803% | +182M shares |
| 5 years | +9519% | +190M shares |
CNCK has 192M diluted shares, up 47% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has the edge over CNCK on leverage, with a lower net debt burden relative to earnings.
CNCK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 85.4x | High |
| Q1 2026 | -66.8x | Net Cash |
| Q3 2024 | 0.0x | Very low |
| Q2 2024 | -2.5x | Net Cash |
| Q1 2024 | 9.9x | High |
| Q4 2023 | -2,695.0x | Net Cash |
| Q4 2022 | 0.0x | Very low |
| Q3 2022 | -5.3x | Net Cash |
CNCK's net debt is more than 20 years of its operating earnings (EBITDA), up from 9.9 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CNCK.
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
CNCK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.0 | Neutral |
| Stochastic | 2.8 | Oversold |
CNCK's weekly RSI is 32 (neutral) and its Stochastic is 3 (oversold).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
CNCK PE vs Financial Services Sector
CNCK has no meaningful PE right now: it lost money over the past year.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK has stronger trend alignment. BLK is above 5 of 5 weekly averages versus CNCK above 0 of 4.
CNCK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 17% below |
| 20 week MA | $1.85 | 41% below |
| 50 week MA | $2.17 | 49% below |
| 100 week MA | $4.03 | 73% below |
CNCK is in a downtrend: it's below all four of its weekly moving averages, and 73% below its 100-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has the edge over CNCK on returns for 2026, with the stronger performance.
CNCK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.9 | $8.50 | -39% |
| 2025 | $8.50 | $3.48 | -59% |
| 2026 YTD | $3.48 | $1.10 | -68% |
CNCK has finished every year since 2024 lower, and it's down 68% so far in 2026.